Agenda 2025
SKIP THE LINES! | Thursday, October 9, 2025
3:30 – 6:30 PM Sign-In, Pick up your badge & handout early! | Salon G/H Foyer
Agenda - Friday, October 10, 2025
*All times are Eastern Daylight Time (EDT)
6:45 – 7:30 AM |
Registration and Breakfast | Please Visit Exhibits |
|
7:15 – 7:30 AM | Virtual Attendees Sign-in to Online Platform | |
7:30 – 7:40 AM | Welcome and Introductions Francis Marchlinski, MD |
|
SESSION I |
||
7:40 – 7:50 AM |
CT vs MRI for Definition of Scar Substrates and Emerging Role of Photon Counting CT |
|
7:50 – 8:00 AM |
Non-invasive Assessment of the Ventricular Arrhythmogenic Substrate: ECGi in Combination with CMR |
|
8:00 – 8:10 AM |
Near Field Analysis and ADAS Software to Localize Potential Ablation Sites |
|
8:10 – 8:20 AM |
RCT – in EuroHeart – Study Results and Potential Implications |
|
8:20 – 8:30 AM |
Image Based Dissection of Ventricular Tachycardia Circuitry: Bridging the Gap Between Structure and Electrical Activity |
|
8:30 – 8:50 AM |
Panel Discussion with Q&A Session |
|
SESSION II |
||
8:50 – 9:00 AM |
Device Prevention of SCD: Where Are We in 2025 |
|
9:00 – 9:10 AM |
New Systems for Treating VT Without Intravascular Leads |
|
9:10 – 9:20 AM |
Clinical Value in Visualization of the Conduction System for CRT |
|
9:20 – 9:30 AM |
Left Bundle Pacing and Optimized CRT with Novel ICD Leads |
|
9:30 – 9:40 AM |
Can Quantitative Vector Screening for SubQ ICD Reduce Inappropriate Shocks? |
|
9:40 – 10:00 AM |
EP Heavyweight Debate |
|
10:00 – 10:20 AM |
Panel Discussion with Q&A Session |
|
10:20 – 10:40 AM |
Coffee Break | Visit Exhibits |
|
SESSION III |
||
10:40 – 10:50 AM |
AI Assisted ECG as a Risk Prediction Tool for VF |
|
10:50 – 11:00 AM |
Updates on the His-Purkinje System in VF |
|
11:00 – 11:10 AM |
Multicenter Study of Idiopathic VF: Detection of Etiological Diagnosis (hidden diseases) by Long Term Monitoring |
|
11:10 – 11:20 AM |
Distinguishing Pseudo Torsades de Pointes from True Torsades de Pointes |
|
11:20 – 11:30 AM |
Prerecorded Case of VF Ablation – Bordeaux Strategy |
|
11:30 – 11:40 AM |
Bravo Study and Brugada Syndrome: Clinical Implications Koonlawee Nadamanee, MD |
|
11:40 AM – 12:00 PM |
Panel Discussion with Q&A Session |
|
12:00 – 12:05 PM |
Pick up Box Lunch |
|
|
SESSION IV Hospital of University of Pennsylvania, Philadelphia, PA Operators/Onsite discussants:
|
|
|
SESSION V |
|
1:50 – 2:00 PM |
How Connexin and Ion Channel Alterations Combine to Build the Functional Part of the VT Substrate |
|
2:00 – 2:10 PM |
How Gene Therapy Amends the Electrophysiologic Substrate |
|
2:10 – 2:20 PM |
Detailed Substrate Distribution and Outcome after Catheter Ablation in Gene Positive and Gene Elusive Patients with NICM |
|
2:20 – 2:30 PM |
Overcoming the Arrhythmia Management Challenges Posed by Myocardial Inflammation |
|
2:30 – 240 PM |
Desmosomal Ultrastructure to Identify Novel Molecular Targets for VT Ablation |
|
2:40 – 3:00 PM |
Panel Discussion with Q&A Session |
|
3:00 – 3:20 PM |
Coffee Break | Visit Exhibits |
|
|
SESSION VI |
|
3:20 – 3:30 PM |
Results from the LESS VT Study in NICM |
|
3:30 – 3:40 PM |
Brazilian BiV versus CSP RCT |
|
3:40 – 3:50 PM |
VT Symposium LBCT Competition/TBD |
|
3:50 – 4:00 PM |
VT Symposium LBCT Competition/TBD |
|
4:00 – 4:20 PM |
Panel Discussion |
|
|
New/Ongoing Trials – Rapid Fire Presentations |
|
4:20 – 4:27 PM |
Radiate VT Update |
|
4:27 – 4:34 PM |
FACILE VT Roderick Tung, MD |
|
4:34 – 4:41 PM | EASY-R: Outcomes with a Novel Pericardial Access Tool Petr Neuzil MD, PhD |
|
4:41 – 4:48 PM | Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT Douglas Packer, MD |
|
4:48 – 4:55 PM | Words of Advice – Are we Heading in the Right Direction? David Callans, MD |
|
|
SESSION VII |
|
4:55 – 5:05 PM |
The Misleading QRS: Discrepancies Between VT Morphology and Site of Origin |
|
5:05 – 5:15 PM |
ARVC VT: Endo Ablation-Who Benefits? Targeting ICE defined RV Aneurysms for Better Outcome |
|
5:15 – 5:25 PM |
Progress in Mapping Fixed Versus Functional Block in VT Substrate Ablation |
|
5:25 – 5:35 PM |
Cardiogenetic Disease: Role of the Immune System |
|
5:35 – 5:45 PM |
Pacemapping for VT Ablation: New Insights |
|
5:45 – 5:55 PM |
Presence of Mid-Myocardial Fibrosis in Ventricular Endocardial Electrograms is Related to Power of Patient-Specific Frequency Bands |
|
5:55 – 6:05 PM |
PFA for Bailout VT Ablation in USA – Early Clinical Experience + Some Challenges to Overcome |
|
6:05 – 6:25 PM |
Panel Discussion with Q&A Session |
|
6:25 – 6:30 PM |
Day 1 Wrap up |
|
6:30 – 7:30 PM |
Welcome Reception Best Abstract Finalist Posters and Highlights from Late Breaking Trial Results |